The segment has immense growth potential driven by the country's increasing healthcare needs, technological innovations, government support, and emerging market opportunities
Till 30th November 2024, more than 2690 PACS have been given initial approval and 687 Kendras have been opened in PACS
The Scheme is subject to approval of the secured creditors and shareholders of TML and GTBL
The recognition from Malaysia's NPRA, a member of PIC/S, opens doors to new global business opportunities
Union Government will provide a health cover of Rs. 5 lakh to any elderly person above 70 years of age
The share subscription agreements are being executed at a pre-money equity value of US$ 1.65 billion
We now rank 3rd in pharmaceutical production by volume and 14th by value
India called for stronger investments in health and social equity at G20 Joint Finance-Health Task Force Meeting
Lasa Supergenerics Limited has been granted patent for an invention “Processes for Preparation and Purification of 5-Chloro-2-Nitroaniline
The company will now seek final approval from NCLT, Mumbai Bench, and upon its receipt, OneSource will proceed to seek listing approvals from the BSE and NSE
Subscribe To Our Newsletter & Stay Updated
